<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-9ZAYHU9A</identifier><date>2005</date><creator>Oven, Irena</creator><relation>documents/znanstveni_clanki/radiology_and_oncology/html/urn_nbn_si_doc-9zayhu9a.html</relation><relation>documents/znanstveni_clanki/radiology_and_oncology/pdf/urn_nbn_si_doc-9zayhu9a.pdf</relation><relation>documents/znanstveni_clanki/radiology_and_oncology/txt/urn_nbn_si_doc-9zayhu9a.txt</relation><format format_type="volume">39</format><format format_type="issue">4</format><format format_type="main">8 strani</format><format format_type="type">article</format><format format_type="extent">str. 261-268</format><identifier identifier_type="ISSN">1318-2099</identifier><identifier identifier_type="COBISSID">1837704</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-9ZAYHU9A</identifier><language>eng</language><publisher>Association of Radiology and Oncology</publisher><source>Radiology and oncology (Ljubljana)</source><rights>BY</rights><subject language_type_id="slv">imunoterapija</subject><subject language_type_id="slv">onkologija</subject><subject language_type_id="slv">rak (medicina)</subject><subject language_type_id="slv">tumorji</subject><title>MHC class II molecules and tumour immunotherapy</title></Record>